Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 4Unknown 2Terminated 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 6Lymphoid 4Myeloid 3Head & Neck 2Gynecologic 2Dermatologic 2Breast 2Sarcoma 1Plasma cell 1Other solid neoplasm 1Genitourinary 1Classical hematology 1CNS 1

Conditions

Head and Neck Neoplasms 2

Interventions

Cisplatin 108Radiotherapy 44Docetaxel 44Radiotherapy, Intensity-Modulated 35Gemcitabine 31Fluorouracil 30camrelizumab 24toripalimab 21Drug Therapy 21Cetuximab 20apatinib 19Paclitaxel 16Carboplatin 16pembrolizumab 14Chemoradiotherapy 14Capecitabine 13sintilimab 12nimotuzumab 12Blood Specimen Collection 12Surveys and Questionnaires 10Surgical Procedures, Operative 10Endostatins 10Cyclophosphamide 9nedaplatin 8endostar protein 8durvalumab 8Nivolumab 8Neoadjuvant Therapy 8Induction Chemotherapy 8fludarabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Flow Cytometry × Head & Neck × Clear all
NCT00589186 2013-12-18

Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
35 enrolled
Head & Neck

Head and Neck Neoplasms

NCT00690872 2009-06-29

Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
35 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡